Volatile Anesthetics in Ischemic Liver Injury: Enemy or Friend?

authors:

avatar Masood Mohseni 1 , avatar Saeid Safari 1 , 2 , avatar Seyed Moayed Alavian ORCID 2 , 3 , *

Department of Anesthesiology, Iran University of Medical Sciences, Tehran, IR Iran
Middle East Liver Diseases Center (MELD), Tehran, IR Iran
Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Hepatitis Monthly: Vol.14, issue 6; e19880
published online: June 1, 2014
article type: Editorial
received: April 30, 2014
accepted: May 1, 2014
DOI: https://doi.org/10.5812/hepatmon.19880

how to cite: Mohseni M, Safari S, Alavian S M. Volatile Anesthetics in Ischemic Liver Injury: Enemy or Friend?. Hepat Mon. 2014;14(6):e19880. https://doi.org/10.5812/hepatmon.19880.

Acknowledgements

References

  • 1.

    Bahde R, Spiegel HU. Hepatic ischaemia-reperfusion injury from bench to bedside. Br J Surg. 2010;97(10):1461-75. [PubMed ID: 20645395]. https://doi.org/10.1002/bjs.7176.

  • 2.

    Fuhrmann V, Jager B, Zubkova A, Drolz A. Hypoxic hepatitis - epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr. 2010;122(5-6):129-39. [PubMed ID: 20361374]. https://doi.org/10.1007/s00508-010-1357-6.

  • 3.

    Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury. Am J Surg. 2001;181(2):160-6. [PubMed ID: 11425059].

  • 4.

    Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg. 2003;238(6):843-50. [PubMed ID: 14631221]. https://doi.org/10.1097/01.sla.0000098620.27623.7d.

  • 5.

    Heidenberg WJ, Torio IS, Cebula J. Halothane hepatitis. An American disease? Lancet. 1963;1(7292):85-6. [PubMed ID: 13953338].

  • 6.

    Lehmann K, Clavien PA. History of hepatic surgery. Surg Clin North Am. 2010;90(4):655-64. [PubMed ID: 20637939]. https://doi.org/10.1016/j.suc.2010.04.018.

  • 7.

    Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007;356(15):1545-59. [PubMed ID: 17429086]. https://doi.org/10.1056/NEJMra065156.

  • 8.

    Khajavi M, Emami A, Etezadi F, Safari S, Sharifi A, Shariat Moharari R. Conscious Sedation and Analgesia in Colonoscopy: Ketamine/Propofol Combination has Superior Patient Satisfaction Versus Fentanyl/Propofol. Anesth Pain Med. 2013;3(1):208-13. [PubMed ID: 24223364]. https://doi.org/10.5812/aapm.9653.

  • 9.

    Yang LQ, Tao KM, Liu YT, Cheung CW, Irwin MG, Wong GT, et al. Remifentanil preconditioning reduces hepatic ischemia-reperfusion injury in rats via inducible nitric oxide synthase expression. Anesthesiology. 2011;114(5):1036-47. [PubMed ID: 21383616]. https://doi.org/10.1097/ALN.0b013e3182104956.

  • 10.

    Azmude A, Agha'amou S, Yousefshahi F, Berjis K, Mirmohammad'khani M, Sadaat'ahmadi F, et al. Pregnancy outcome using general anesthesia versus spinal anesthesia for in vitro fertilization. Anesth Pain Med. 2013;3(2):239-42. [PubMed ID: 24282775]. https://doi.org/10.5812/aapm.11223.

  • 11.

    Khan ZH. Pain management in intensive care unit patients: the role of ultra-short acting opioid: remifentanil. Anesth Pain Med. 2013;3(1):188-90. [PubMed ID: 24223360]. https://doi.org/10.5812/aapm.10299.

  • 12.

    Beck-Schimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M, et al. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg. 2008;248(6):909-18. [PubMed ID: 19092335]. https://doi.org/10.1097/SLA.0b013e31818f3dda.

  • 13.

    Selzner N, Boehnert M, Selzner M. Preconditioning, postconditioning, and remote conditioning in solid organ transplantation: basic mechanisms and translational applications. Transplant Rev (Orlando). 2012;26(2):115-24. [PubMed ID: 22000660]. https://doi.org/10.1016/j.trre.2011.07.003.

  • 14.

    Gurusamy KS, Kumar Y, Pamecha V, Sharma D, Davidson BR. Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion. Cochrane Database Syst Rev. 2009;(1):CD007629. [PubMed ID: 19160339]. https://doi.org/10.1002/14651858.CD007629.

  • 15.

    Theodoraki K, Tympa A, Karmaniolou I, Tsaroucha A, Arkadopoulos N, Smyrniotis V. Ischemia/reperfusion injury in liver resection: a review of preconditioning methods. Surg Today. 2011;41(5):620-9. [PubMed ID: 21533932]. https://doi.org/10.1007/s00595-010-4444-4.

  • 16.

    Beck-Schimmer B, Breitenstein S, Bonvini JM, Lesurtel M, Ganter M, Weber A, et al. Protection of pharmacological postconditioning in liver surgery: results of a prospective randomized controlled trial. Ann Surg. 2012;256(5):837-44. [PubMed ID: 23095629]. https://doi.org/10.1097/SLA.0b013e318272df7c.

  • 17.

    Maines MD. The heme oxygenase system: update 2005. Antioxid Redox Signal. 2005;7(11-12):1761-6. [PubMed ID: 16356137]. https://doi.org/10.1089/ars.2005.7.1761.

  • 18.

    Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006;86(2):583-650. [PubMed ID: 16601269]. https://doi.org/10.1152/physrev.00011.2005.

  • 19.

    Barrier A, Olaya N, Chiappini F, Roser F, Scatton O, Artus C, et al. Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J. 2005;19(12):1617-26. [PubMed ID: 16195370]. https://doi.org/10.1096/fj.04-3445com.

  • 20.

    Habibollahi P, Mahboobi N, Esmaeili S, Safari S, Dabbagh A, Alavian SM. Halothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis. Hepat Mon. 2011;11(1):3-6. [PubMed ID: 22087107].

  • 21.

    Dabbagh A, Rajaei S. The Role of Anesthetic Drugs in Liver Apoptosis. Hepat Mon. 2013;13(8). ee13162. [PubMed ID: 24069040]. https://doi.org/10.5812/hepatmon.13162.

  • 22.

    Mahboobi N, Esmaili S, Safari S, Habibollahi P, Dabbagh A, Alavian SM. Halothane: How should it be treated in a developing country? EMHJ. 2011.

  • 23.

    Gut J. Molecular basis of halothane hepatitis. Arch Toxicol Suppl. 1998;20:3-17. [PubMed ID: 9442277].

  • 24.

    Habibollahi P, Mahboobi N, Esmaeili S, Safari S, Dabbagh A, Alavian SM. Halothane-induced hepatitis: A forgotten issue in developing countries. Hepat Mon. 2011;11(1):3.

  • 25.

    Eger EI, 2nd, Smuckler EA, Ferrell LD, Goldsmith CH, Johnson BH. Is enflurane hepatotoxic? Anesth Analg. 1986;65(1):21-30. [PubMed ID: 3940466].

  • 26.

    Elliott RH, Strunin L. Hepatotoxicity of volatile anaesthetics. Br J Anaesth. 1993;70(3):339-48. [PubMed ID: 8471380].

  • 27.

    Gelman S. General anesthesia and hepatic circulation. Can J Physiol Pharmacol. 1987;65(8):1762-79. [PubMed ID: 3319112].

  • 28.

    Holaday DA, Fiserova-Bergerova V, Latto IP, Zumbiel MA. Resistance of isoflurane to biotransformation in man. Anesthesiology. 1975;43(3):325-32. [PubMed ID: 1163832].

  • 29.

    Gunza JT, Pashayan AG. Postoperative elevation of serum transaminases following isoflurane anesthesia. J Clin Anesth. 1992;4(4):336-41. [PubMed ID: 1419017].

  • 30.

    Brunt EM, White H, Marsh JW, Holtmann B, Peters MG. Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: a case report. Hepatology. 1991;13(6):1017-21. [PubMed ID: 2050317].

  • 31.

    Turner GB, O'Rourke D, Scott GO, Beringer TR. Fatal hepatotoxicity after re-exposure to isoflurane: a case report and review of the literature. Eur J Gastroenterol Hepatol. 2000;12(8):955-9. [PubMed ID: 10958225].

  • 32.

    Hoetzel A, Leitz D, Schmidt R, Tritschler E, Bauer I, Loop T, et al. Mechanism of hepatic heme oxygenase-1 induction by isoflurane. Anesthesiology. 2006;104(1):101-9. [PubMed ID: 16394696].

  • 33.

    Gatecel C, Losser MR, Payen D. The postoperative effects of halothane versus isoflurane on hepatic artery and portal vein blood flow in humans. Anesth Analg. 2003;96(3):740-5. [PubMed ID: 12598255].

  • 34.

    Kanaya N, Nakayama M, Fujita S, Namiki A. Comparison of the effects of sevoflurane, isoflurane and halothane on indocyanine green clearance. Br J Anaesth. 1995;74(2):164-7. [PubMed ID: 7696065].

  • 35.

    Bedirli N, Ofluoglu E, Kerem M, Utebey G, Alper M, Yilmazer D, et al. Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model. Anesth Analg. 2008;106(3):830-7. [PubMed ID: 18292427]. https://doi.org/10.1213/ane.0b013e3181616fc9.

  • 36.

    Sutton TS, Koblin DD, Gruenke LD, Weiskopf RB, Rampil IJ, Waskell L, et al. Fluoride metabolites after prolonged exposure of volunteers and patients to desflurane. Anesth Analg. 1991;73(2):180-5. [PubMed ID: 1854033].

  • 37.

    Malhotra P, Mychaskiw G, Rai A. Desflurane versus opioid anesthesia for cardiac shunt procedures in infants with cyantoic congential heart disease. Anesth Pain Med. 2013;3(1):191-7. [PubMed ID: 24223361]. https://doi.org/10.5812/aapm.9511.

  • 38.

    Hartman JC, Pagel PS, Proctor LT, Kampine JP, Schmeling WT, Warltier DC. Influence of desflurane, isoflurane and halothane on regional tissue perfusion in dogs. Can J Anaesth. 1992;39(8):877-87. [PubMed ID: 1288912]. https://doi.org/10.1007/BF03008300.

  • 39.

    Weiskopf RB, Eger EI, 2nd, Ionescu P, Yasuda N, Cahalan MK, Freire B, et al. Desflurane does not produce hepatic or renal injury in human volunteers. Anesth Analg. 1992;74(4):570-4. [PubMed ID: 1554124].

  • 40.

    Ko JS, Gwak MS, Choi SJ, Kim GS, Kim JA, Yang M, et al. The effects of desflurane and propofol-remifentanil on postoperative hepatic and renal functions after right hepatectomy in liver donors. Liver Transpl. 2008;14(8):1150-8. [PubMed ID: 18668648]. https://doi.org/10.1002/lt.21490.

  • 41.

    Kotake Y. [Anesthetic protection against hepatic injury]. Masui. 2006;55(5):570-8. [PubMed ID: 16715911].